US Edition2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
10 Articles
10 Articles
This is probably a historic moment for the fight against human immunodeficiency virus (HIV). The U.S. Health Authorities have approved a preventive treatment to fight HIV. Yeztugo:...
The United States has approved a new preventive treatment against the AIDS virus (HIV), announced Wednesday the pharmaceutical laboratory Gilead that is developing it, a green light that could revolutionize the fight against this epidemic, even if the issue of its accessibility remains whole.
These hopes could be dashed by astronomical prices. Although the company did not disclose it, analysts estimate that the launch price in the United States could rise to $25,000 a year.
The United States has approved a new, long-awaited treatment for HIV prevention, announced Wednesday the pharmaceutical laboratory Gilead that is developing it. ...
2025 Warren Alpert Prize Honors Scientists Whose Discoveries Culminated in Novel HIV Treatment
First-in-class medication halts HIV replication by disrupting a critical piece of the viral machinery -- the capsid protein shell that protects the vial genome.
The new treatment will now be available for “adults and adolescents who sing at least 35 kg”. “This is a historic day in the fight against HIV”, said Daniel O’Day, CEO of the American biotechnology company. Yeztugo is significantly more effective than the existing oral medicines for HIV prevention. Named Yeztugo, the treatment consisting of two annual injections, could revolutionize the fight against HIV and AIDS by facilitating significant care…
Coverage Details
Bias Distribution
- 50% of the sources lean Left
To view factuality data please Upgrade to Premium
